Elsewhere on Ulster
This project is funded by:
A greater understanding of preventive and therapeutic strategies for obesity and type 2 diabetes (T2DM) is needed.
Early intervention and lifestyle adjustments can slow, stop and even reverse prediabetes. While omega-3 polyunsaturated fatty acids (PUFAs) are known for cardiovascular benefits, their effects on T2DM remain less clear.
Free-fatty-acid G-protein coupled receptors (GPCRs) play a role in counteracting early islet-cell dysfunction, impaired insulin secretion, insulin resistance and inflammation in T2DM.
Our research shows that omega-3 PUFA receptors in pancreatic islets and intestinal cells promote glucose-lowering, insulinotropic, and incretin effects, while also reducing risk and improving metabolic control in obesity, and type 2 diabetes.
This studentship will validate omega-3’s benefits on energy expenditure, fuel utilization and incretin release in metabolic disease.
Our aims are to: investigate GPCR-targeted omega-3 therapy on diabetes progression in pre-clinical studies using knockout models; define omega-3-induced GPCR-signalling mechanisms in peripheral tissues using CRISPR/Cas9 gene-editing; and assess the metabolic effects of PUFAs in humans with T2DM.
This research will provide excellent translational research training, strengthen understanding of druggable GPCR pathways to support future personalized therapies and drug development.
The studentship aims to investigate:
Important Information: Applications for more than one PhD studentship are welcome, however if you apply for more than one PhD project within Biomedical Sciences, your first application on the system will be deemed your first-choice preference and further applications will be ordered based on the sequential time of submission.
If you are successfully shortlisted, you will be interviewed only on your first-choice application and ranked accordingly. Those ranked highest will be offered a PhD studentship.
In the situation where you are ranked highly and your first-choice project is already allocated to someone who was ranked higher than you, you may be offered your 2nd or 3rd choice project depending on the availability of this project.
Applicants should hold, or expect to obtain, a First or Upper Second Class Honours Degree in a subject relevant to the proposed area of study.
We may also consider applications from those who hold equivalent qualifications, for example, a Lower Second Class Honours Degree plus a Master’s Degree with Distinction.
In exceptional circumstances, the University may consider a portfolio of evidence from applicants who have appropriate professional experience which is equivalent to the learning outcomes of an Honours degree in lieu of academic qualifications.
If the University receives a large number of applicants for the project, the following desirable criteria may be applied to shortlist applicants for interview.
The University is an equal opportunities employer and welcomes applicants from all sections of the community, particularly from those with disabilities.
Appointment will be made on merit.
This project is funded by:
This scholarship will cover tuition fees and provide a maintenance allowance of £21,000* (tbc) per annum for three years (subject to satisfactory academic performance). A Research Training Support Grant (RTSG) of approximately £900 per annum is also available.
To be eligible for these scholarships, applicants must meet the following criteria:
Applicants should also meet the residency criteria which requires that they have lived in the EEA, Switzerland, the UK or Gibraltar for at least the three years preceding the start date of the research degree programme.
Applicants who already hold a doctoral degree or who have been registered on a programme of research leading to the award of a doctoral degree on a full-time basis for more than one year (or part-time equivalent) are NOT eligible to apply for an award.
Due consideration should be given to financing your studies.
*Part time PhD scholarships may be available, based on 0.5 of the full time rate, and will require a six year registration period
1. Owolabi AI, Corbett RC, Flatt PR, McKillop AM. (2024) Positive interplay between FFAR4/GPR120, DPPIV inhibition and GLP-1 in beta cell proliferation and glucose homeostasis in obese high fat fed mice. Peptides 177:171218 2024.
2. McKillop AM, Miskelly MG, Moran BM, Flatt PR. (2023) Incretins play an important role in FFA4/GPR120 regulation of glucose metabolism by GW-9508. Life Sciences. 318:121475.
3. McCloskey AG, Miskelly MG, Lafferty RA, Flatt PR, McKillop AM. (2023) Antidiabetic actions of GPR55 agonist Abn-CBD and sitagliptin in obese-diabetic high fat fed mice. Biochem Pharmacol. 208:115398.
4. Mohan S, McCloskey AG, McKillop AM, Flatt PR, Irwin N, Moffett RC. (2021) Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice. Biochim Biophys Acta Gen Subj. 1865(3):129811.
5. McCloskey AG, Miskelly MG, Moore TCB, Nesbit MA, Christie K, Owolabi A, Flatt PR, McKillop AM. (2020) CRISPR/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function. Peptides. 125:170251.
Submission deadline
Friday 27 February 2026
04:00PM
Interview Date
23rd March - 3rd April 2026
Preferred student start date
14th September 2026
Telephone
Contact by phone
Email
Contact by email